Ravulizumab | m-entrepreneurship.com

Product Name :
Ravulizumab

Search keywords :
Ravulizumab

drugId :
null

Target Vo:
Complement C5

Target Vo Short Name :
C5

Moa_Name:
Complement C5 inhibitors

First Approval Country :
United States

First Approval Date Filter:
2018

Origin Company_Name :
Alexion Pharmaceuticals Inc

Active Company_Name :
Alexion Athlone Manufacturing Facility

Active Indication_Name:
Neuromyelitis Optica

In Active Indication_Name:
Pneumonia, Viral

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:
NDA/BLA

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Teclistamab Autophagy
PKC alpha Rabbit mAb Technical Information
CARS Antibody: CARS Antibody is a non-conjugated and Rabbit origined monoclonal antibody about 85 kDa, targeting to CARS. It can be used for WB,IHC-P assays with tag free, in the background of Human, Rat.

Author: Betaine hydrochloride

Related Posts